Finally, to further confirm the relationship between the MAMs and lipid deposition in the kidney, we observed decreased expression of MAM-control proteins (DsbA-L, PACS-2, and MFN-2) in different stages of DN, and they were associated with lipid deposition and renal damage. This evidence concerns the gene MFN2 and liver dysplastic nodule.